Newsbenzinga
Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…